Piper Jaffray has downgraded Exact Sciences (NASDAQ:
EXAS) from Overweight to Neutral and has lowered the price target from $10 to $8.
© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
To add Benzinga News as your preferred source on Google, click here.
